All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - Min
Long-term complications after stent assist coiling dependent on clopidogrel response
Read more...
The utility of platelet inhibition testing in patients undergoing Pipeline embolization of intracranial aneurysms
Read more...
The inhibition rate estimated using VerifyNow can help to predict the thromboembolic risk of coil embolization for unruptured intracranial aneurysms
Read more...
Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
Read more...
Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the Hemochron® Response and Hemochron® Signature Elite
Read more...
Chemiluminescence in Hemostasis
Read more...
Esportazione utenti registrati
Read more...
D3 - Session 6 - D-Dimer and Sepsis
Read more...
D3 - Session 5 - D-Dimer and Arterial Diseases
Read more...
D3 - Session 3 - Analytical Aspects of D-Dimer Assays
Read more...
D3 - Session 2 - General Overview of Fibrinolysis
Read more...
D3 - Session 1 - Covid19 Associated Coagulopathies: A Year in Review
Read more...
Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device
Read more...
Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneury
Read more...
Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device
Read more...
Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value
Read more...
Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device
Read more...
Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response
Read more...
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
Read more...
Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
Read more...
Risk Factor Analysis of Delayed Intracerebral Hemorrhage After Coil Embolization of Unruptured Cerebral Aneurysms
Read more...
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collabo
Read more...
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Read more...
Percutaneous Coronary Intervention With an Initial Bolus of Low-Dose Heparin in Biomarker-Negative Patients
Read more...
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Read more...
STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass
Read more...
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
Read more...
Use of an objective tool to assess platelet inhibition prior to off-pump coronary surgery to reduce blood usage
Read more...
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration
Read more...
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery
Read more...
Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention
Read more...
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Read more...
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis
Read more...
Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass
Read more...
How do we manage cardiopulmonary bypass coagulopathy?
Read more...
Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery
Read more...
Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study
Read more...
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Read more...
Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow
Read more...
Monitoring platelet reactivity during prasugrel or ticagrelor washout before urgent coronary artery bypass grafting
Read more...
The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions
Read more...
Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
Read more...
Evaluating the effectiveness of pre-operative platelet inhibition testing to reduce costs and pre-operative length of stay
Read more...
Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series
Read more...
Weight as an assay-independent predictor of poor response to enteric aspirin in cardiovascular patients
Read more...
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Read more...
Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series
Read more...
Platelet Activity Measured by VerifyNow® Aspirin Sensitivity Test Identifies Coronary Artery Bypass Surgery Patients at Increased Risk for Postoperative Bleeding and Transfusion
Read more...
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
Read more...
Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction
Read more...
Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
Read more...
Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes
Read more...
Open-label multicenter registry on the outcomes of peripheral arterial disease treated by balloon angioplasty with optical frequency domain imaging in superficial femoral artery and popliteal artery (OCEAN-SFA study)
Read more...
Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Read more...
Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity
Read more...
Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
Read more...
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
Read more...
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Read more...
Using heparin molecules to manage COVID-2019
Read more...
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
Early coagulation tests predict risk stratification and prognosis of COVID-19
Read more...
COVID-19 Related Coagulopathy: A Distinct Entity?
Read more...
The compelling arguments for the need of microvascular investigation in COVID-19 critical patients
Read more...
Fibrinolysis and COVID‐19: A plasmin paradox
Read more...
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Read more...
Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill
Read more...
Heparin - An old drug with multiple potential targets in Covid-19 therapy
Read more...
D-dimer Triage for COVID-19
Read more...
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Read more...
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Read more...
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
Read more...
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Curative anticoagulation prevents endothelial lesion in COVID-19 patients
Read more...
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Read more...
Coagulopathy in COVID-19
Read more...
The unique characteristics of COVID-19 coagulopathy
Read more...
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Read more...
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Read more...
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis
Read more...
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Read more...
Essential Role of Patient Blood Management in a Pandemic: A Call for Action
Read more...
Current Perspectives of Anticoagulation in Patients With COVID-19
Read more...
Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
Read more...
Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
Read more...
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Read more...
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Read more...
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Read more...
https://pubmed.ncbi.nlm.nih.gov/32339221/
Read more...
Hematological findings and complications of COVID-19
Read more...
COVID-19-associated coagulopathy: An exploration of mechanisms
Read more...
Understanding the COVID-19 coagulopathy spectrum
Read more...
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)
Read more...
D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
Read more...
Start
Prev
1
2
3
4
Next
End
Page 2 of 4
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection